Find clinical trials for Endometrial Cancer in Birmingham, AL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Endometrial Cancer trials near Birmingham, AL, USA:
The goal of this clinical trial is to assess if circulating tumor DNA can guide adjuvant selection in high-intermediate risk early-stage endometrial...
Birmingham, Alabama, United States and 8 other locations
This is a single arm, Phase II study using the combination of atezolizumab and bevicacizumab in women with advanced, recurrent or persistent endometrial...
Phase 2
Birmingham, Alabama, United States and 2 other locations
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
global, multi-arm study to evaluate efficacy and safety of relacorilant in combination with other treatments in patients with gynecological cancers...
Phase 2
Birmingham, Alabama, United States and 48 other locations
The purpose of this study is to compare pembrolizumab + adjuvant chemotherapy with placebo + adjuvant chemotherapy, with or without radiotherapy, wit...
Phase 3
Birmingham, Alabama, United States and 230 other locations
can be given alone or with cemiplimab to patients with ovarian cancer or cancer of the uterus* The study will also look at the leve...
Phase 1, Phase 2
Birmingham, Alabama, United States and 52 other locations
antitumor activity of IMGN151 in adult participants with recurrent endometrial cancer; recurrent, high-grade serous epithelial ovar...
Phase 1
Birmingham, Alabama, United States and 57 other locations
This study will test the safety of a drug called PF-08046054/SGN-PDL1V alone and with pembrolizumab in participants with solid tumors. It wi ...
Phase 1
Birmingham, Alabama, United States and 60 other locations
The objective of this study is to evaluate the safety, tolerability, and efficacy of BL-M07D1 in patients with HER2 expressing advanced tumors...
Phase 1
Birmingham, Alabama, United States and 16 other locations
to participants with locally advanced or metastatic solid tumors with certain KRAS mutations. LY4066434 will be given alone or in combinatio...
Phase 1
Birmingham, Alabama, United States and 57 other locations
This clinical trial is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors. The main goals of this stu...
Phase 1, Phase 2
Birmingham, Alabama, United States and 79 other locations
Clinical trials
Research sites
Resources
Legal